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ABSTRACT 
 
 
The Dopamine Transporter (DAT) is a trans-membrane protein that binds 
dopamine and transports it into the cell, removing it from the synapse and terminating the 
signal to the post-synaptic cell. The endocytic pathway by which DAT internalizes is yet 
unknown. Dynamin is a GTPase that is known to be involved in the budding of vesicles 
during some endocytic pathways. The present study was performed to determine if DAT 
internalizes via a dynamin-dependent endocytic pathway. Data shows that DAT 
internalization is not dynamin-dependent and implicates that dynamin may be involved in 
recycling DAT to the cell surface. 
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BACKGROUND 
 
 
The Dopamine Transporter 
 The Dopamine Transporter (DAT) is a trans-membrane protein that binds 
dopamine and transports it into the cell, removing it from the synaptic cleft and 
terminating the dopaminergic signal to the post-synaptic cell. Dopamine is an important 
neurotransmitter necessary in the central nervous system for correct motor function and 
rewarding behaviors. As such, the dopamine transporter has been implicated in a number 
of neurological disorders including attention deficit hyperactivity disorder, schizophrenia, 
and Parkinson’s disease. DAT has also been linked to drug addiction because it is the 
target of many psychostimulants such as cocaine and amphetamines, which competitively 
inhibit the transporter’s ability to remove DA from the synapse and cause an increase in 
the duration and magnitude of the synaptic signal. Fully understanding the activity and 
trafficking of DAT is vital for the potential treatment of these neurological disorders and 
addictions. 
 DAT is a member of the SLC6 transporter gene family that is characterized by the 
transporters’ dependency on sodium and chloride ions for paired transport of dopamine 
into the cell. Other members of the SLC6 family include serotonin, norepinephrine and 
GABA transporters. All members of this gene family are highly homologous, having 
twelve transmembrane domains and a conserved endocytic signal (Figure 1).  
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Dopamine Transporter Internalization and Recycling 
 Protein trafficking via internalization and recycling plays a vital role in neuronal 
function. In the synapse, neurotransmitters are released by exocytosis and removed again 
by transporters. These transporters and the synaptic signal are regulated through 
transporter internalization and recycling. Dopamine reuptake by DAT terminates 
dopaminergic neurotransmission and is mediated by DA transporters. A careful balance 
must be maintained between the release and reuptake of dopamine to ensure proper 
dopaminergic neurotransmission.  
Several studies have demonstrated that phorbal ester activation of protein kinase 
C (PKC) results in a decreased capacity of DAT to reuptake DA into the cell due to a 
decrease in DAT on the cell surface (Melikian & Buckley, 1999). The redistributing of 
DAT from the cell surface to endosomal compartments is what causes DA transport 
down-regulation following PKC activation (Loder & Melikian, 2003). This down-
regulation is achieved by simultaneously increasing basal DAT endocytosis and slowing 
DAT delivery to the cell-surface (Holton et al, 2005). PKC relies on the endocytic signal 
that is conserved in the SLC6 family members at residues 587-596 “FREKLAYAIA” 
(Boudanova et al, 2008). Although the endocytic signal is known, the mechanism by 
Figure 1: Structure of the 
Dopamine Transporter (DAT) 
DAT is an SLC6 transporter with 12 
transmembrane domains and the 
endocytic signal “FREKLAYAIA” 
 (Melikian, 1999). 
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which DAT is endocytosed still remains unclear. A study using bafilomycin A1 to 
facilitate recycling blockade has shown however that the DAT endocytic mechanism is 
distinct from the clathrin- and dynamin- dependent mechanism utilized by the transferrin 
receptor (Loder & Melikian, 2003). 
 
The GTPase Dynamin 
Dynamin is a large GTPase protein with a molecular weight of ~100kDa.  As a 
GTPase, dynamin’s main catalytic activity is the hydrolysis of GTP to GDP.  The 
Dynamin I isoform is found primarily in neuronal cells and is the main isoform of 
interest. In its purified form, the protein is observed to spontaneously oligermerize in the 
form of rings and spirals.  
Dynamin has been shown to be essential for vesicle budding in clathrin-dependent 
as well as other endocytic pathways, specifically at a late stage during the transition from 
a fully formed pit on the cell surface to pinched-off vesicle. This was first demonstrated 
by observations of a temperature sensitive mutation in the Drosophila shibire gene, 
which is a homologue to the human dynamin-I gene. In this study, flies observed at the 
nonpermissive temperature revealed a loss of synaptic vesicles and an accumulation of 
both coated and uncoated invaginations at the synaptic membrane (Damke et al, 1994). 
Furthermore, studies of human dynamin using a mutant that is defective in GTP binding 
and hydrolysis demonstrated that coated vesicles at the surface of cells expressing the 
mutant failed to constrict or bud from the membrane, indicating that dynamin is 
specifically required for coated vesicle endocytosis, in particular its GTP binding and 
hydrolysis activities (Damke et al, 1994). 
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In the mechanochemical models of activity, dynamin assembles as a collar on the 
neck of a budding vesicular pit, and the cooperative conformational change that 
accompanies GTP-hydrolysis leads to neck constriction and scission of the vesicle from 
the plasma membrane (Figure 2) (Macia et al, 2006). Additionally, it has been determined 
that when dynamin catalyzes GTP hydrolysis, it undergoes a conformation change in 
which it expands in length and contracts in width, resulting in the fission of the vesicle 
(Hill et al, 2009; Takei et al, 2005). 
 
 
 
 In addition to clathrin-mediated endocytosis, dynamin has been linked to transport 
from the trans-Golgi network, free vesicle formation by fission of caveolae from the 
plasma membrane and tubule fission from early endosomal compartments (Kirchhausen 
et al, 2006; Mesaki et al, 2011) 
. 
Dynamin Inhibition 
In recent years, several small molecule inhibitors of dynamin activity have been 
discovered and synthesized. Such small molecule inhibitors are useful because they allow 
Figure 2: Mechanochemical 
Model of Dynamin-Dependent 
Endocytosis 
Illustration of dynamin’s role in 
membrane vesicle budding (Doherty 
& McMahon, 2009). 
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researchers to freeze biological processes, permitting them to observe transient 
phenomena, such as membrane trafficking, that were nearly impossible to view when 
using prior methods of temperature sensitive mutants or permanent and nonspecific 
inhibition of GTP binding (Kirchhausen et al, 2008). Small molecule inhibitors are also 
useful because they are highly cell permeable and their effects can be reversed through 
washout (Hill et al, 2009; Kirchhausen et al, 2006). 
Two important small molecule inhibitors of dynamin that were used in this study 
are Dynasore and Dynole 34-2. Dynasore is a noncompetitive inhibitor of dynamin I, II, 
and mitochondrial dynamin (Macia et al, 2006). Studies using Dynasore have shown it to 
be a potent inhibitor of known dynamin-dependent endocytic pathways by blocking 
coated vesicle formation within the first 1-2 minutes of exposure (Macia et al, 2006). The 
inhibitor Dynole 34-2 was discovered and synthesized more recently than Dynasore and 
is the most potent member of an indole-based inhibitor family known as dynoles (Hill et 
al, 2009). Dynole 34-2 inhibition of dynamin is also noncompetitive and studies suggest 
that the molecule must bind to an allosteric site that may become available upon binding 
of GTP to the enzyme’s active site (Hill et al, 2009). The creators of Dynole 34-2 were 
also able to conclude that it was a superior dynamin inhibitor to Dynasore because it was 
15-fold more active against dynamin I than Dynasore and it is more membrane permeable 
than Dynasore due to the lipophilic nature of the whole dynole family (Hill et al, 2009). 
There have been previous studies using small molecule inhibitors to test the role 
of dynamin in synaptic vesicle endocytosis. Some of these studies claim that dynamin 
plays an undisputed role in synaptic vesicle recycling. One particular study concluded 
that dynamin is essential for all forms of synaptic vesicle endocytosis and that inhibition 
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of dynamin by Dynasore had no alternative effect on exocytosis (Newton et al, 2006). 
However, this claim is not consistent to data obtained during the experiments for this 
project. Another study demonstrated that the inhibition of LDL cholesterol trafficking by 
Dynasore led to an abnormal accumulation of the internalized cholesterol in the 
endolysosomal network (Girard et al, 2011). An additional study has demonstrated that 
dynamin inhibition with Dynasore prevents tubule fission from early endosome 
compartments, sequestering 63.2% of internalized transferrin within the compartment and 
impairing recycling to the cell surface (Mesaki et al, 2011). This sequestering of 
cholesterol and transferrin is more consistent with the apparent sequestration of DAT 
observed in this project. 
 
 
 
 
  
 
 11 
PROJECT PURPOSE 
 
 This project was completed to experimentally determine the potential role of the 
GTPase dynamin in DAT endocytosis. While previous studies had shown that DAT did 
not internalize via the same clathrin-mediated endocytic pathway as transferrin, the 
particular mechanism utilized by DAT and whether this mechanism relied on dynamin 
for vesicular budding remained unknown. Characterization of the effects of dynamin 
inhibition on DA uptake in cultured cell lines would help elucidate the endocytic pathway 
by which DAT internalizes. The hypothesis being tested states that DAT internalization 
occurs via a dynamin-dependent but clathrin-independent pathway.  
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METHODS 
Cell Lines and Culture 
The cell line utilized in this study was of PC12 cells stably expressing hDAT. 
PC12 cells are derived from pheochromocytoma of the rat adrenal medulla. The cells 
were cultured at 37°C 10%CO2 in DMEM supplemented with 5% Horse Serum, 5% 
Bovine Calf Serum, 2mM Glutamine, 102 units/ml Penicillin/Streptomycin antibiotic and 
0.2mg/ml G418 to ensure expression of DAT. 
 
Plasma Membrane Transport Assays 
 DAT PC12 cells were maintained in cell culture as described above. Cells were 
plated at a density of 2.5x105 cells per well in 24 well scintillation plates. Before plating, 
each well was washed with 0.5 mg/ml poly-D-lysine to provide a layer for the PC12 cells 
to adhere to and prevent loss of cells during later washes of the assay. After 15 minutes 
the wells were washed with PBS to remove excess poly-D-lysine. Cells were plated and 
allowed to incubate for 24 hours. Following incubation, the cells were washed three times 
with KRH buffer (120 nM NaCl, 4.7mM KCl, 1.2mM MgSO4, 1.2mM KH2PO4, 2.2mM 
CaCl2, and 10mM HEPES, pH 7.4). A 0.18% glucose in KRH solution was used in the 
preparation of drugs for the membrane transport assays. All assays had a total volume of 
250μl.	  Dynamin	  inhibiting	  drugs,	  Dynasore	  or	  Dynole,	  were	  added	  to	  their	  respective	  wells	  and	  allowed	  to	  pre-­‐incubate	  for	  an	  allotted	  time.	  Following	  the	  pre-­‐incubation,	  the	  cells	  were	  subsequently	  incubated	  with	  any	  other	  drugs	  being	  tested.	  After	  all	  drug	  incubations,	  [3H]DA	  in	  a	  10μM	  pargyline	  and	  10μM	  ascorbic	  acid	  supplemented	  KRH/glucose	  solution	  was	  added	  to	  each	  well.	  The	  specific	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activity	  of	  the	  [3H]DA	  cocktail	  was	  diluted	  20x	  by	  adding	  nonradioactive	  DA	  to	  obtain	  the	  desired	  concentration.	  Endogenous	  NE	  transporter	  activity	  was	  blocked	  by	  adding	  0.1μM	  DMI	  to	  each	  well.	  Non-­‐specific	  counts	  were	  obtained	  by	  using	  GBR	  12909	  to	  block	  DAT	  activity.	  In	  some	  assays,	  PMA	  was	  used	  to	  observe	  rapid	  DAT	  down-­‐regulation.	  After	  incubating	  with	  [3H]DA	  for	  10	  minutes,	  the	  cells	  were	  washed	  three	  times	  with	  ice	  cold	  KRH	  buffer	  to	  halt	  transporter	  activity.	  Cells	  were	  then	  lysed	  in	  250μl	  scintillation	  fluid	  while	  shaking	  for	  15	  minutes	  before	  the	  plate	  was	  counted	  in	  a	  scintillation	  counter.	   
 Plasma membrane transport assays were also performed to observe [3H] Alanine 
uptake. These assays followed nearly the same procedure as those for [3H]DA with the 
exception that non-specific counts were obtained by removing Na+ from any solutions 
that the cells in the NS condition were treated with. This was accomplished by making a 
KRH solution with Choline in place of Sodium Chloride (120 nM Choline, 4.7mM KCl, 
1.2mM MgSO4, 1.2mM KH2PO4, 2.2mM CaCl2, and 10mM HEPES, pH 7.4). Alanine 
uptake assays also lacked DMI because endogenous NE transport was irrelevant or 
pargyline and ascorbic acid in the [3H]Ala cocktails. 
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RESULTS 
 
 
The purpose of this study was to experimentally determine the role of the GTPase 
dynamin in DAT endocytosis. Previously, dynamin had been shown to be involved in the 
budding of vesicles during several endocytic mechanisms, including clathrin-mediated 
endocytosis. However, additional studies have determined that DAT does not internalize 
via the same clathrin-mediated endocytic pathway as transferrin, and the particular 
mechanism utilized by DAT and whether this mechanism relies on dynamin for vesicular 
budding remains unknown. The original hypothesis being tested was that DAT 
internalization utilizes a dynamin-dependent endocytic pathway. 
 
Studies of DA Uptake with Dynamin Inhibition  
 In order to determine whether dynamin is involved in DAT trafficking, dopamine 
uptake assays were performed on PC12 cells that stably expressed DAT. DA uptake 
assays were performed ±dynamin inhibitor ±	  the	  phorbal	  ester,	  PMA. Incubation with 
PMA results in DAT down-regulation through rapid internalization of the transporter. If 
Dynamin were involved in DAT endocytosis, incubation of DAT PC12 cells with a 
Dynamin inhibitor, either Dynasore or Dynole, would prevent or reduce this down-
regulation. Incubation with PMA alone exhibited a loss in DA uptake characteristic of 
phorbal ester down-regulation; a 75% loss of specific DA uptake with Dynole (Figure 
3A) and 70% loss with Dynasore (Figure 3B). In the case of both dynamin inhibitors, 
there was also a loss of specific DA uptake when incubated with the dynamin inhibitor 
alone. There was a 65% loss seen with Dynole (Figure 3A) and a 41% loss with 
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Dynasore (Figure 3B).  An even more drastic loss of specific uptake was observed when 
DAT PC12 cells were incubated first with a dynamin inhibitor and then again with PMA. 
There was a total loss of 82% specific DA uptake when using Dynole and PMA(Figure 
3A) total of 80.4% loss of specific uptake when using Dynasore and PMA(Figure 3B).  
  
        
The failure of dynamin inhibition to block or reduce PMA-mediated DAT down-
regulation leads to the conclusion that DAT endocytosis must be dynamin-independent. 
However, because dynamin inhibition caused a reduction in DA uptake, dynamin must be 
involved at some other stage in the processing or recycling of internalized DAT. 
 
 
** ** 
Figure 1A: Effect of Dynole on 
PMA-Mediated DAT Down-
Regulation 
[3H]DA uptake ±Dynole ±PMA is 
measured as a percentage of vehicle 
DA uptake. *Significantly different 
from Vehicle, p<0.01 ** p<0.001, 
One-way ANOVA w/ Tukey’s 
Multiple Comparison test, n=7. 
Figure 1B: Effect of Dynasore on 
PMA-Mediated DAT Down-
Regulation 
[3H]DA uptake ±Dynasore ±PMA is 
measured as a percentage of vehicle 
DA uptake. *Significantly different 
from Vehicle, p<0.01 ** p<0.001, 
One-way ANOVA w/ Tukey’s 
Multiple Comparison test, n=4. 
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DA Uptake Kinetics Following Dynamin Inhibition 
After it was observed that dynamin inhibition caused a loss of specific DA uptake 
on its own, it was decided that the kinetics of DAT’s interaction with DA in the presence 
of a dynamin inhibitor should be studied to determine how the addition of a dynamin 
inhibitor reduced DA transport. In the kinetics assays, uptake was recorded ±Dynasore 
with varying concentrations of [3H]DA. These were performed to determine any changes 
caused by dynamin inhibition in either the maximum velocity of DA binding at saturation 
(Vmax) or the concentration at which the velocity was half of Vmax (Km) of DA transport. 
Data from theses assays showed a drastic decrease in the Vmax following Dynasore 
treatment as can be seen in a representative Michaelis-Menton curve in Figure 4A.   
 
Figure 4A: Michaelis-Menton 
Kinetics of DA Uptake ±Dynasore 
Velocity of [3H]DA uptake ±Dynole 
is measured at DA concentrations of  
0.1, 0.3, 0.6, 1.0, 3.0 and 6.0μM.  
Graph is representative of at least 6 
independent experiments. 
Figure 4B: Effect of Dynasore on 
the Vmax of DA Uptake Kinetics 
Vmax ±Dynasore is measured as a 
percentage of the vehicle Vmax. 
*Significantly different from 
Vehicle, p<0.05 Unpaired t test, 
n=6. 
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 Over the course of six kinetics experiments, it was observed that there was a 
significant decrease in Vmax following dynamin inhibition, but no significant change in 
Km. On average, the Vmax in the presence of Dynasore was only 48.3% of the vehicle Vmax 
(Figure 4B). 
 
[3H] Alanine Uptake Following Dynamin Inhibition 
To test if the loss in DA uptake and decrease in Vmax that occurred following 
dynamin inhibition was the result of any disruption by the dynamin inhibiting drugs to 
either the cell membrane or the Na+ gradient that DAT relies on for transport, [3H] 
Alanine uptake assays were performed ±Dynole. Alanine transport in PC12 cells is Na+ 
dependent and an altering of the Na+ gradient would be reflected in [3H]Ala uptake. 
Concurrently, a disruption of the dynamics of the plasma membrane could also be 
reflected in [3H] Alanine uptake.  
 
The 3H Alanine studies showed that there was no significant loss in 3H Alanine 
uptake in the presence of Dynole and if anything, there was a trend that 3H Alanine 
uptake increased in its presence (Figure 5). Additionally, it suggested that the loss in DA 
Figure 5: Effect of Dynole on  Na+ 
Dependent Alanine Uptake 
[3H]Alanine uptake ±Dynole is 
measured as a percentage of vehicle 
Alanine uptake. There is no 
significant difference between 
conditions p>0.05. 
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uptake following dynamin inhibition was not the result of any Na+ gradient change or a 
disruption of the cell membrane that would cause interrupted transporter functions. 
 
Dynamin Inhibition Time Course 
When it was determined that DAT internalization was dynamin-independent, 
further studies were performed to attempt to determine what point in DAT recycling was 
dynamin-dependent. To test this, time course assays were performed. In the time course, 
DAT PC12 cells were incubated with the dynamin-inhibitor Dynole for 5, 10, 15, 20, 30 
and 45 minute intervals to determine how long of an incubation was needed for an effect.  
 
The assays revealed that there was a drastic loss in specific DA uptake after only 
5 minutes incubation with Dynole (Figure 6). Overall this was observed to be an average 
65% loss of specific uptake and that Dynole reduced DA uptake regardless of the 
incubation period. 
 
 
 
Figure 6: Effect of Dynole on DA 
Uptake  
[3H]DA uptake ±Dynole is 
measured as a percentage of vehicle 
DA uptake. Cells were incubated 
with Dynole for 5, 10, 15, 20, 30 
and 45 minutes.  
n=3. 
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DISCUSSION 
 
 
 
The overall conclusion that can be made from these experiments is that the 
dopamine transporter is internalized via a dynamin-independent endocytic pathway. The 
failure of dynamin inhibition to block or reduce PMA-mediated DAT down-regulation 
leads to this conclusion.  
Furthermore, because there was an observed loss in DA uptake when cells were 
treated solely with a dynamin inhibitor and an additional loss in DA uptake when cells 
were treated with PMA following dynamin inhibition, the study suggests that dynamin 
must be involved at some subsequent stage in DAT trafficking. According to Michaelis-
Menton kinetics, the observed reduction in the Vmax of DA uptake following treatment 
with dynamin indicates that the transporter has either become inactivated or there has 
been a loss of total transporter from the system. Data from [3H] Alanine uptake assays 
can be used to infer that the loss in DA uptake from the dynamin inhibitor Dynole is not 
the result of a Na+ gradient change or a disruption of the plasma membrane that would 
cause interrupted transporter functions. Therefore, the decrease in Vmax must be due to a 
subtraction of DAT from the cell surface and the inhibition of dynamin must sequester 
DAT in some compartment within the cell, suggesting that dynamin is involved at some 
point in the processing or recycling of internalized DAT. 
Further studies on the internalization and recycling pathways utilized by DAT are 
needed to fully understand how exactly dynamin is involved in DAT trafficking. Cell 
surface biotinylation experiments could be used to quantitatively measure changes in 
DAT levels on the cell surface following dynamin inhibition. Immunocytochemistry 
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experiments are needed to observe where DAT is sequestered in the presence of a 
dynamin inhibitor and whether it co-localizes in any particular compartment, such as 
early endosomes, endosomal recycling compartments or lysosomes. Additionally, further 
experiments should be performed to determine the nature of the apparently dynamin- and 
clathrin-independent endocytic pathway utilized by DAT. 
The dopamine transporter has been implicated in a number of neurological 
disorders including Bipolar Disorder, Attention Deficit Disorder, and drug addiction. 
Fully understanding the activity and trafficking of DAT is vital for the potential treatment 
of such disorders. The data from this MQP can help narrow down the possible endocytic 
pathways that could be employed in DAT endocytosis by eliminating any that are 
dynamin-dependent. Furthermore, the data raises new questions into how many other 
pathways there may be for the internalization of plasma membrane vesicles. 
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